Literature DB >> 22291017

Adaptor protein cerebral cavernous malformation 3 (CCM3) mediates phosphorylation of the cytoskeletal proteins ezrin/radixin/moesin by mammalian Ste20-4 to protect cells from oxidative stress.

Miguel Fidalgo1, Ana Guerrero, María Fraile, Cristina Iglesias, Celia M Pombo, Juan Zalvide.   

Abstract

While studying the functions of CCM3/PDCD10, a gene encoding an adaptor protein whose mutation results in vascular malformations, we have found that it is involved in a novel response to oxidative stress that results in phosphorylation and activation of the ezrin/radixin/moesin (ERM) family of proteins. This phosphorylation protects cells from accidental cell death induced by oxidative stress. We also present evidence that ERM phosphorylation is performed by the GCKIII kinase Mst4, which is activated and relocated to the cell periphery after oxidative stress. The cellular levels of Mst4 and its activation after oxidative stress depend on the presence of CCM3, as absence of the latter impairs the phosphorylation of ERM proteins and enhances death of cells exposed to reactive oxygen species. These findings shed new light on the response of cells to oxidative stress and identify an important pathophysiological situation in which ERM proteins and their phosphorylation play a significant role.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22291017      PMCID: PMC3322875          DOI: 10.1074/jbc.M111.320259

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  The Ste20 group kinases as regulators of MAP kinase cascades.

Authors:  I Dan; N M Watanabe; A Kusumi
Journal:  Trends Cell Biol       Date:  2001-05       Impact factor: 20.808

2.  Cloning of MASK, a novel member of the mammalian germinal center kinase III subfamily, with apoptosis-inducing properties.

Authors:  Ippeita Dan; Shao-En Ong; Norinobu M Watanabe; Blagoy Blagoev; Mogens M Nielsen; Eriko Kajikawa; Troels Z Kristiansen; Matthias Mann; Akhilesh Pandey
Journal:  J Biol Chem       Date:  2001-12-06       Impact factor: 5.157

3.  Ezrin is a downstream effector of trafficking PKC-integrin complexes involved in the control of cell motility.

Authors:  T Ng; M Parsons; W E Hughes; J Monypenny; D Zicha; A Gautreau; M Arpin; S Gschmeissner; P J Verveer; P I Bastiaens; P J Parker
Journal:  EMBO J       Date:  2001-06-01       Impact factor: 11.598

4.  In vitro characterization of the angiogenic phenotype and genotype of the endothelia derived from sporadic cerebral cavernous malformations.

Authors:  Yuan Zhu; Qun Wu; Moritz Fass; Jin-Fang Xu; Chao You; Oliver Müller; I Erol Sandalcioglu; Jian-Min Zhang; Ulrich Sure
Journal:  Neurosurgery       Date:  2011-09       Impact factor: 4.654

5.  Caspase activation of mammalian sterile 20-like kinase 3 (Mst3). Nuclear translocation and induction of apoptosis.

Authors:  Chi-Ying F Huang; Yi-Mi Wu; Chiung-Yueh Hsu; Wan-Shu Lee; Ming-Derg Lai; Te-Jung Lu; Chia-Lin Huang; Tzeng-Horng Leu; Hsiu-Ming Shih; Hsin-I Fang; Dan R Robinson; Hsing-Jien Kung; Chiun-Jye Yuan
Journal:  J Biol Chem       Date:  2002-07-09       Impact factor: 5.157

6.  Slik Sterile-20 kinase regulates Moesin activity to promote epithelial integrity during tissue growth.

Authors:  David R Hipfner; Nadine Keller; Stephen M Cohen
Journal:  Genes Dev       Date:  2004-09-15       Impact factor: 11.361

7.  Dysfunction of mouse liver mitochondria induced by 2,2'-azobis-(2-amidinopropane) dihydrochloride, a radical initiator, in vitro and in vivo.

Authors:  T Kanno; T Utsumi; A Ide; Y Takehara; T Saibara; J Akiyama; T Yoshioka; K Utsumi
Journal:  Free Radic Res       Date:  1994-09

8.  Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations.

Authors:  Christina L Liquori; Michel J Berg; Adrian M Siegel; Elizabeth Huang; Jon S Zawistowski; T'Prien Stoffer; Dominique Verlaan; Fiyinfolu Balogun; Lori Hughes; Tracey P Leedom; Nicholas W Plummer; Milena Cannella; Vittorio Maglione; Ferdinando Squitieri; Eric W Johnson; Guy A Rouleau; Louis Ptacek; Douglas A Marchuk
Journal:  Am J Hum Genet       Date:  2003-11-17       Impact factor: 11.025

9.  Morphogenic effects of ezrin require a phosphorylation-induced transition from oligomers to monomers at the plasma membrane.

Authors:  A Gautreau; D Louvard; M Arpin
Journal:  J Cell Biol       Date:  2000-07-10       Impact factor: 10.539

10.  YSK1 is activated by the Golgi matrix protein GM130 and plays a role in cell migration through its substrate 14-3-3zeta.

Authors:  Christian Preisinger; Benjamin Short; Veerle De Corte; Erik Bruyneel; Alexander Haas; Robert Kopajtich; Jan Gettemans; Francis A Barr
Journal:  J Cell Biol       Date:  2004-03-22       Impact factor: 10.539

View more
  35 in total

Review 1.  STRIPAK complexes in cell signaling and cancer.

Authors:  Z Shi; S Jiao; Z Zhou
Journal:  Oncogene       Date:  2016-02-15       Impact factor: 9.867

2.  Systems biology and proteomic analysis of cerebral cavernous malformation.

Authors:  Alexander R Edelmann; Sarah Schwartz-Baxter; Christopher F Dibble; Warren C Byrd; Jim Carlson; Ivandario Saldarriaga; Sompop Bencharit
Journal:  Expert Rev Proteomics       Date:  2014-03-31       Impact factor: 3.940

3.  Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS.

Authors:  Markku Varjosalo; Roberto Sacco; Alexey Stukalov; Audrey van Drogen; Melanie Planyavsky; Simon Hauri; Ruedi Aebersold; Keiryn L Bennett; Jacques Colinge; Matthias Gstaiger; Giulio Superti-Furga
Journal:  Nat Methods       Date:  2013-03-03       Impact factor: 28.547

Review 4.  STRIPAK complexes: structure, biological function, and involvement in human diseases.

Authors:  Juyeon Hwang; David C Pallas
Journal:  Int J Biochem Cell Biol       Date:  2013-12-11       Impact factor: 5.085

5.  Update on Novel CCM Gene Mutations in Patients with Cerebral Cavernous Malformations.

Authors:  Concetta Scimone; Placido Bramanti; Concetta Alafaci; Francesca Granata; Francesco Piva; Carmela Rinaldi; Luigi Donato; Federica Greco; Antonina Sidoti; Rosalia D'Angelo
Journal:  J Mol Neurosci       Date:  2016-12-20       Impact factor: 3.444

Review 6.  Cerebral cavernous malformation proteins at a glance.

Authors:  Kyle M Draheim; Oriana S Fisher; Titus J Boggon; David A Calderwood
Journal:  J Cell Sci       Date:  2014-01-30       Impact factor: 5.285

Review 7.  Cerebral cavernous malformation is a vascular disease associated with activated RhoA signaling.

Authors:  Bryan T Richardson; Christopher F Dibble; Asya L Borikova; Gary L Johnson
Journal:  Biol Chem       Date:  2013-01       Impact factor: 3.915

8.  Strategy for identifying repurposed drugs for the treatment of cerebral cavernous malformation.

Authors:  Christopher C Gibson; Weiquan Zhu; Chadwick T Davis; Jay A Bowman-Kirigin; Aubrey C Chan; Jing Ling; Ashley E Walker; Luca Goitre; Simona Delle Monache; Saverio Francesco Retta; Yan-Ting E Shiu; Allie H Grossmann; Kirk R Thomas; Anthony J Donato; Lisa A Lesniewski; Kevin J Whitehead; Dean Y Li
Journal:  Circulation       Date:  2014-12-08       Impact factor: 29.690

9.  Loss of endothelial programmed cell death 10 activates glioblastoma cells and promotes tumor growth.

Authors:  Yuan Zhu; Kai Zhao; Anja Prinz; Kathy Keyvani; Nicole Lambertz; Ilonka Kreitschmann-Andermahr; Ting Lei; Ulrich Sure
Journal:  Neuro Oncol       Date:  2015-08-08       Impact factor: 12.300

10.  Adipocyte morphology and implications for metabolic derangements in acquired obesity.

Authors:  S Heinonen; L Saarinen; J Naukkarinen; A Rodríguez; G Frühbeck; A Hakkarainen; J Lundbom; N Lundbom; K Vuolteenaho; E Moilanen; P Arner; S Hautaniemi; A Suomalainen; J Kaprio; A Rissanen; K H Pietiläinen
Journal:  Int J Obes (Lond)       Date:  2014-02-19       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.